Olive has raised $902 million across multiple rounds, including a landmark $400M Series H in July 2021 at a $4B valuation. Earlier, the company secured $226 million in Series G funding (2020) at a $1.5 billion valuation and $106 million in Series F, bringing its total capital above $700 million within one year. Backed by Tiger Global, Dragoneer, Vista Equity, and General Catalyst, Olive rapidly scaled its AI automation platform for healthcare administration. Founded in 2012, the company achieved unicorn status within 8 years and 11 months, becoming one of the fastest-scaling AI startups in healthcare IT.